Neon Therapeutics Overview
Neon Therapeutics General Information
Description
Neon Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused in the field of neoantigen-targeted therapies, dedicated to transforming the treatment of cancer by directing the immune system towards neoantigens. The company's pipeline products are NEO-PV-01, NEO-PTC-01, and NEO-SV-01.
Want to dig into this profile?
We’ll help you find what you need
Learn more
Neon Therapeutics Valuation & Funding
| Deal Type |
Date |
Amount |
Raised to Date |
Post-Val |
Status |
Stage |
| 4. Merger/Acquisition |
06-May-2020 |
$67M |
00000 |
0000 |
Completed |
Generating Revenue |
| 3. IPO |
27-Jun-2018 |
00000 |
00000 |
00000 |
Completed |
Generating Revenue |
| 2. Early Stage VC (Series B) |
05-Dec-2017 |
$106M |
$161M |
00000 |
Completed |
Startup |
| 1. Early Stage VC (Series A) |
01-Oct-2015 |
$55M |
$55M |
0000 |
Completed |
Startup |
Neon Therapeutics Cap Table
To view Neon Therapeutics‘s complete cap table, request access >>
| Stock |
# of Shares
Authorized |
Par Value |
Dividend Rate ($) |
Original
Issue Price |
Liquidation |
Liquidation
Pref. Multiple |
Conversion Price |
% Owned |
| Series B |
00,000,000 |
00.000000 |
00.00 |
00.00 |
00.00 |
00 |
00.00 |
00.000 |
| Series A |
00,000,000 |
00.000000 |
00.00 |
00 |
00 |
00 |
00 |
00.000 |
Neon Therapeutics Competitors (51)
| Company Name |
Financing Status |
Location |
Employees |
Total Raised |
Last Financing Date/Type |
Last Financing
Amount |
| UNUM Therapeutics |
Formerly VC-backed |
Cambridge, MA |
00 |
00000 |
000000 - 000 |
00000 |
| 000000000000 |
Venture Capital-Backed |
Seattle, WA |
00 |
000.00 |
00000000000 |
000.00 |
| 0000000 0000000000 |
Formerly VC-backed |
Redwood City, CA |
00 |
00000 |
000000&0 |
00000 |
| 000000 00000000000 |
Formerly VC-backed |
South San Francisco, CA |
000 |
00000 |
000000 - 000 |
00000 |
| 000000 00000000000 |
Corporation |
PA |
000 |
000.00 |
00000000 |
000.00 |
Neon Therapeutics Executive Team (15)
| Name |
Title |
Board Seat |
Contact Info |
| Hugh O'Dowd |
Chief Executive Officer & Board Member |
|
|
| Richard Gaynor |
President |
|
|
| Yasir Al-Wakeel |
Chief Financial Officer, Finance & Chief Accounting Officer, Accounting |
|
|
| Robert Ang MD |
Executive |
|
|
11 Former Executives